Legis Daily

Overdose Prevention and Patient Safety Act

USA115th CongressHR-5795| House 
| Updated: 6/12/2018
Earl Blumenauer

Earl Blumenauer

Democratic Representative

Oregon

Cosponsors (31)
Michael C. Burgess (Republican)Markwayne Mullin (Republican)Randy Hultgren (Republican)Kristi L. Noem (Republican)Derek Kilmer (Democratic)Neal P. Dunn (Republican)Sanford D. Bishop (Democratic)Lynn Jenkins (Republican)Greg Walden (Republican)Suzan K. DelBene (Democratic)Bruce Poliquin (Republican)Peter A. DeFazio (Democratic)Todd Rokita (Republican)Vicente Gonzalez (Democratic)James B. Renacci (Republican)Gus M. Bilirakis (Republican)Andy Barr (Republican)Mike Kelly (Republican)Jacky Rosen (Democratic)John Lewis (Democratic)Kevin Cramer (Republican)Brian J. Mast (Republican)Ami Bera (Democratic)Michael R. Turner (Republican)Ron Kind (Democratic)Charlie Crist (Democratic)Seth Moulton (Democratic)Suzanne Bonamici (Democratic)Susan W. Brooks (Republican)Bill Johnson (Republican)Barbara Comstock (Republican)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Overdose Prevention and Patient Safety Act This bill aligns federal privacy standards for substance use disorder patient records more closely with standards under the Health Insurance Portability and Accountability Act, including authorized disclosures and penalty structures for violations.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2018
Introduced in House
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 17, 2018
Committee Consideration and Mark-up Session Held.
May 17, 2018
Ordered to be Reported (Amended) by the Yeas and Nays: 35 - 17.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 559.
Jun 12, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-724.
  • May 15, 2018
    Introduced in House


  • May 15, 2018
    Referred to the House Committee on Energy and Commerce.


  • May 17, 2018
    Committee Consideration and Mark-up Session Held.


  • May 17, 2018
    Ordered to be Reported (Amended) by the Yeas and Nays: 35 - 17.


  • June 12, 2018
    Placed on the Union Calendar, Calendar No. 559.


  • June 12, 2018
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-724.

Health

Related Bills

  • HR 115-5807: To amend the Controlled Substances Act to allow for more flexibility with respect to medication-assisted treatment for opioid use disorders and to amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.
  • HR 115-6082: Overdose Prevention and Patient Safety Act
Administrative law and regulatory proceduresCriminal investigation, prosecution, interrogationDepartment of Health and Human ServicesDisability and health-based discriminationDrug, alcohol, tobacco useEmployment discrimination and employee rightsEvidence and witnessesHealth information and medical recordsHealth personnelHealth programs administration and fundingHousing discriminationMedical educationPrescription drugsRight of privacy

Overdose Prevention and Patient Safety Act

USA115th CongressHR-5795| House 
| Updated: 6/12/2018
Overdose Prevention and Patient Safety Act This bill aligns federal privacy standards for substance use disorder patient records more closely with standards under the Health Insurance Portability and Accountability Act, including authorized disclosures and penalty structures for violations.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2018
Introduced in House
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 17, 2018
Committee Consideration and Mark-up Session Held.
May 17, 2018
Ordered to be Reported (Amended) by the Yeas and Nays: 35 - 17.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 559.
Jun 12, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-724.
  • May 15, 2018
    Introduced in House


  • May 15, 2018
    Referred to the House Committee on Energy and Commerce.


  • May 17, 2018
    Committee Consideration and Mark-up Session Held.


  • May 17, 2018
    Ordered to be Reported (Amended) by the Yeas and Nays: 35 - 17.


  • June 12, 2018
    Placed on the Union Calendar, Calendar No. 559.


  • June 12, 2018
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-724.
Earl Blumenauer

Earl Blumenauer

Democratic Representative

Oregon

Cosponsors (31)
Michael C. Burgess (Republican)Markwayne Mullin (Republican)Randy Hultgren (Republican)Kristi L. Noem (Republican)Derek Kilmer (Democratic)Neal P. Dunn (Republican)Sanford D. Bishop (Democratic)Lynn Jenkins (Republican)Greg Walden (Republican)Suzan K. DelBene (Democratic)Bruce Poliquin (Republican)Peter A. DeFazio (Democratic)Todd Rokita (Republican)Vicente Gonzalez (Democratic)James B. Renacci (Republican)Gus M. Bilirakis (Republican)Andy Barr (Republican)Mike Kelly (Republican)Jacky Rosen (Democratic)John Lewis (Democratic)Kevin Cramer (Republican)Brian J. Mast (Republican)Ami Bera (Democratic)Michael R. Turner (Republican)Ron Kind (Democratic)Charlie Crist (Democratic)Seth Moulton (Democratic)Suzanne Bonamici (Democratic)Susan W. Brooks (Republican)Bill Johnson (Republican)Barbara Comstock (Republican)

Energy and Commerce Committee

Health

Related Bills

  • HR 115-5807: To amend the Controlled Substances Act to allow for more flexibility with respect to medication-assisted treatment for opioid use disorders and to amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.
  • HR 115-6082: Overdose Prevention and Patient Safety Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCriminal investigation, prosecution, interrogationDepartment of Health and Human ServicesDisability and health-based discriminationDrug, alcohol, tobacco useEmployment discrimination and employee rightsEvidence and witnessesHealth information and medical recordsHealth personnelHealth programs administration and fundingHousing discriminationMedical educationPrescription drugsRight of privacy